Garofalo Health Care SpA
MIL:GHC

Watchlist Manager
Garofalo Health Care SpA Logo
Garofalo Health Care SpA
MIL:GHC
Watchlist
Price: 5.24 EUR Market Closed
Market Cap: €472.6m

Wall St Price Targets

GHC Price Targets Summary
Garofalo Health Care SpA

Wall Street analysts forecast GHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GHC is 6.02 EUR with a low forecast of 5.96 EUR and a high forecast of 6.2 EUR.

Lowest Forecast
Price Target
5.96 EUR
14% Upside
Average Forecast
Price Target
6.02 EUR
15% Upside
Highest Forecast
Price Target
6.2 EUR
18% Upside
Garofalo Health Care SpA Competitors:
Price Targets
FCL
FINEOS Corporation Holdings PLC
41% Upside
HURN
Huron Consulting Group Inc
91% Upside
FILA
FILA Fabbrica Italiana Lapis ed Affini SpA
58% Upside

Revenue
Forecast

16% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
16% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 3%.

Gross Profit
Forecast

16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Garofalo Health Care SpA

Operating Income
Forecast

18% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
18% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 9 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 4 years is 6%.

Pre-Tax Income
Forecast

16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Garofalo Health Care SpA

Net Income
Forecast

17% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
17% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 3 years is 6%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GHC's stock price target?
Price Target
6.02 EUR

According to Wall Street analysts, the average 1-year price target for GHC is 6.02 EUR with a low forecast of 5.96 EUR and a high forecast of 6.2 EUR.

What is the Revenue forecast for Garofalo Health Care SpA?
Projected CAGR
3%

Over the last 9 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 3%.

What is the Operating Income forecast for Garofalo Health Care SpA?
Projected CAGR
6%

Over the last 9 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 4 years is 6%.

What is the Net Income forecast for Garofalo Health Care SpA?
Projected CAGR
6%

Over the last 9 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 3 years is 6%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett